Disease mongering

Disease mongering is a term used to describe the practice of widening the diagnostic boundaries of illnesses and aggressively promoting their public awareness in order to expand the markets for those who sell and deliver treatments. This concept is often associated with the pharmaceutical industry, which may benefit from increased sales of medications.

Overview

Disease mongering can occur when normal human experiences are redefined as medical conditions. This can lead to the medicalization of normal life processes, such as menopause, erectile dysfunction, and restless legs syndrome. The practice can result in unnecessary medical treatment, increased healthcare costs, and the diversion of resources from more serious health issues.

Mechanisms

Disease mongering can be achieved through several mechanisms:

• Expansion of disease definitions: By broadening the criteria for diagnosing a disease, more individuals can be classified as having the condition. For example, lowering the threshold for hypertension or diabetes can increase the number of people diagnosed.

• Promotion of new diseases: Introducing new medical conditions or syndromes that were previously unrecognized can create new markets. An example is the promotion of social anxiety disorder as a widespread condition requiring treatment.

• Direct-to-consumer advertising: Pharmaceutical companies often use advertising to promote awareness of diseases and their treatments directly to consumers, bypassing healthcare professionals. This can lead to increased demand for specific medications.

Implications

The implications of disease mongering are significant. It can lead to:

• Overdiagnosis and overtreatment: Patients may receive unnecessary treatments, which can have side effects and lead to additional health complications.

• Increased healthcare costs: The expansion of disease categories can lead to higher healthcare spending, as more people seek treatment for conditions that may not require medical intervention.

• Public health concerns: Resources may be diverted from more pressing public health issues to address conditions that have been artificially inflated in importance.

Criticism and Controversy

Critics of disease mongering argue that it exploits patients' fears and vulnerabilities for profit. They call for greater scrutiny of the relationships between healthcare providers and the pharmaceutical industry. There is also a call for more rigorous standards in defining diseases and conditions to prevent unnecessary medicalization.

Related Pages

• Pharmaceutical industry
• Medicalization
• Direct-to-consumer advertising
• Overdiagnosis

‎

• 

  Disease mongering